This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

JOHN Q. OWSLEY, Jr., M.D.; HAROLD A. HARPER, Ph.D.; JOHN M. GOIN, M.D.; JACKSON T. CRANE, M.D.; HORACE J. McCORKLE, M.D.

AMA Arch Surg. 1958;76(5):774-780.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The definitive surgical treatment of portal hypertension secondary to cirrhosis of the liver is intended to lower portal venous pressure and thus prevent hemorrhage from collateral venous channels, usually esophageal varices. Various clinically successful procedures have been developed to shunt the portal blood around the obstructing hepatic vascular bed.¹ A disadvantage of the shunting procedures currently in use is the deleterious effect on hepatic function that may follow a reduction in blood supply to the liver. This has been demonstrated experimentally in dogs with Eck fistulas.^2,3 Deterioration of hepatic function has also been observed in some patients following portacaval shunt.^4,5 By some authors it has been considered problematical whether this hepatic dysfunction might be due to diminution in the total blood supply or simply to diversion of the portal blood.

Silen et al.⁶ have shown that dogs with a surgical transposition of the portal vein and . . . [Full Text PDF of this Article]

Author Affiliations
San Francisco

From the Surgical Research Laboratories of the University of California School of Medicine.

Footnotes
Read at the 65th Annual Meeting of the Western Surgical Association, Salt Lake City, Nov. 22, 1957.

Supported by a grant from the National Institute for Arthritis and Metabolic Diseases (A-1053) and the Christine Breon Fund for Medical Research.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?